日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

围手术期抑制 IDH 治疗初治 IDH 突变型胶质瘤:一项初步试验。

Drummond Katharine J, Spiteri Montana, Cain Sarah A, Jones Jordan, Shaya Sammy, Topp Monique, Lu Tianyao, Tobler Robert, Valkovic Adam L, Moore Zachery, Fatunla Oluwaseun E, Kriel Jurgen, Moffet Joel J D, McAlpine Heidi, Rosier Marius, Guan Hefei, Dimou James, Schadewaldt Verena, Roberts-Thomson Samuel, McArdle David, Lui Elaine, Voelker-Albert Moritz, di Sanzo Simone, Nijagal Brunda, Narayana Vinod K, Mitchell Camilla B, Vissers Joseph H A, Grimmond Sean, Rosenthal Mark A, Palmer Lucy M, Best Sarah A, Freytag Saskia, Whittle James R

Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study

评估三级多学科会诊对转移性乳腺癌的影响:一项前瞻性研究

Sassé, Belinda; Shaya, Sammy; Nimmo, Jessica; Cao, Katie; Day, Daphne; Evans, Katie; Healy, Catherine; Ho, Gwo-Yaw; Kruss, Gillian; McCartney, Amelia; Mojzisova, Linda; Srivastava, Ranjana; Tan, Jennifer; Tan, Mun Yee; Webber, Kate; White, Michelle; David, Steven; Harris, Marion

Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials

循环肿瘤DNA作为早期临床试验参与者筛选的预后生物标志物

Shaya, Sammy; Uche-Ikonne, Okezie; Kilerci, Bedirhan; Stevenson, Julie; Greystoke, Alastair; Cook, Natalie; Thistlethwaite, Fiona C; Carter, Louise; Graham, Donna M; Krebs, Matthew G